🇺🇸 TERLIPRESSIN in United States

204 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Drug Ineffective — 38 reports (18.63%)
  2. Electrocardiogram Qt Prolonged — 23 reports (11.27%)
  3. Renal Impairment — 22 reports (10.78%)
  4. Ascites — 19 reports (9.31%)
  5. Off Label Use — 19 reports (9.31%)
  6. Hepatic Encephalopathy — 18 reports (8.82%)
  7. Multiple Organ Dysfunction Syndrome — 18 reports (8.82%)
  8. Diarrhoea — 16 reports (7.84%)
  9. Toxicity To Various Agents — 16 reports (7.84%)
  10. Product Use In Unapproved Indication — 15 reports (7.35%)

Source database →

TERLIPRESSIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TERLIPRESSIN approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for TERLIPRESSIN in United States?

Marketing authorisation holder not available in our data.